Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Raymond March
37 POSTS
0 COMMENTS
Raymond J. March
is a Research Fellow at the Independent Institute and Assistant Professor of Economics at North Dakota State University.
All Blog Posts
|
Full bio and publications
Three Reasons To Be Optimistic about Pharmaceutical Policy
Raymond March
-
August 2, 2018
0
If Telemedicine Is Underachieving, Government Is to Blame
Raymond March
-
July 11, 2018
0
Misdiagnosing Right-to-try Laws
Raymond March
-
July 6, 2018
0
Putting Right-to-Try Drug Prices in Perspective
Raymond March
-
July 2, 2018
0
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Raymond March
-
June 22, 2018
0
FDA Moves Closer to Approving Ecstasy
Raymond March
-
June 19, 2018
0
Right-to-Try Law Signed!
Raymond March
-
June 18, 2018
0
Curing Diseases Is Sustainable, Government in Healthcare Is Not
Raymond March
-
May 3, 2018
0
FDA Issues First Mandatory Recall for Contaminated Food
Raymond March
-
April 25, 2018
0
FDA Restricts Sale of Contraceptive Device
Raymond March
-
April 18, 2018
0
1
2
3
4
Page 3 of 4
Edit with Live CSS
